These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 16364873)

  • 1. Angiotensin II type 1 receptor antagonist protects ventricular and coronary endothelial function after 24-hour heart preservation.
    Kajihara N; Nishida T; Boku N; Tatewaki H; Eto M; Morita S
    J Heart Lung Transplant; 2005 Dec; 24(12):2211-7. PubMed ID: 16364873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of telmisartan, a unique angiotensin receptor blocker with selective peroxisome proliferator-activated receptor-gamma-modulating activity, on nitric oxide bioavailability and atherosclerotic change.
    Ikejima H; Imanishi T; Tsujioka H; Kuroi A; Kobayashi K; Shiomi M; Muragaki Y; Mochizuki S; Goto M; Yoshida K; Akasaka T
    J Hypertens; 2008 May; 26(5):964-72. PubMed ID: 18398339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
    Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
    J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-nitroso human serum albumin attenuates ischemia/reperfusion injury after cardioplegic arrest in isolated rabbit hearts.
    Semsroth S; Fellner B; Trescher K; Bernecker OY; Kalinowski L; Gasser H; Hallström S; Malinski T; Podesser BK
    J Heart Lung Transplant; 2005 Dec; 24(12):2226-34. PubMed ID: 16364875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AT1 receptor blockade prevents the decrease in conduit artery flow-mediated dilatation during NOS inhibition in humans.
    Bellien J; Iacob M; Eltchaninoff H; Bourkaib R; Thuillez C; Joannides R
    Clin Sci (Lond); 2007 Jun; 112(7):393-401. PubMed ID: 17125466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-Glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the AT1 receptor blocker telmisartan.
    Knorr M; Hausding M; Kröller-Schuhmacher S; Steven S; Oelze M; Heeren T; Scholz A; Gori T; Wenzel P; Schulz E; Daiber A; Münzel T
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2223-31. PubMed ID: 21757654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats.
    Wenzel P; Schulz E; Oelze M; Müller J; Schuhmacher S; Alhamdani MS; Debrezion J; Hortmann M; Reifenberg K; Fleming I; Münzel T; Daiber A
    Free Radic Biol Med; 2008 Sep; 45(5):619-26. PubMed ID: 18539157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of telmisartan on VEGF-induced and VEGF-independent angiogenic responsiveness of coronary endothelial cells in normal and streptozotocin (STZ)-induced diabetic rats.
    Chaudagar KK; Mehta AA
    Clin Exp Hypertens; 2014; 36(8):557-66. PubMed ID: 24490705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor.
    Zhang WW; Bai F; Wang J; Zheng RH; Yang LW; James EA; Zhao ZQ
    Drug Des Devel Ther; 2017; 11():3019-3033. PubMed ID: 29081650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The UW solution has greater potential for longer preservation periods than the Celsior solution: comparative study for ventricular and coronary endothelial function after 24-h heart preservation.
    Kajihara N; Morita S; Tanoue Y; Boku N; Eto M; Nishida T; Tominaga R
    Eur J Cardiothorac Surg; 2006 May; 29(5):784-9. PubMed ID: 16520050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II receptor antagonism with telmisartan increases number of endothelial progenitor cells in normotensive patients with coronary artery disease: a randomized, double-blind, placebo-controlled study.
    Pelliccia F; Pasceri V; Cianfrocca C; Vitale C; Speciale G; Gaudio C; Rosano GM; Mercuro G
    Atherosclerosis; 2010 Jun; 210(2):510-5. PubMed ID: 20044087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telmisartan, a dual ARB/partial PPAR-γ agonist, protects myocardium from ischaemic reperfusion injury in experimental diabetes.
    Goyal SN; Bharti S; Bhatia J; Nag TC; Ray R; Arya DS
    Diabetes Obes Metab; 2011 Jun; 13(6):533-41. PubMed ID: 21320264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization.
    Nagai N; Oike Y; Izumi-Nagai K; Urano T; Kubota Y; Noda K; Ozawa Y; Inoue M; Tsubota K; Suda T; Ishida S
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2252-9. PubMed ID: 16888236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor.
    Nagai N; Noda K; Urano T; Kubota Y; Shinoda H; Koto T; Shinoda K; Inoue M; Shiomi T; Ikeda E; Tsubota K; Suda T; Oike Y; Ishida S
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1078-84. PubMed ID: 15728568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers.
    Kakuta H; Sudoh K; Sasamata M; Yamagishi S
    Int J Clin Pharmacol Res; 2005; 25(1):41-6. PubMed ID: 15864875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephroprotective effect of telmisartan in rats with ischemia/reperfusion renal injury.
    Fouad AA; Qureshi HA; Al-Sultan AI; Yacoubi MT; Al-Melhim WN
    Pharmacology; 2010; 85(3):158-67. PubMed ID: 20150754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin elevation by telmisartan ameliorates ischaemic myocardium in Zucker diabetic fatty rats with metabolic syndrome.
    Rinaldi B; Di Filippo C; Capuano A; Donniacuo M; Sodano L; Ferraraccio F; Rossi F; D'Amico M
    Diabetes Obes Metab; 2012 Apr; 14(4):320-8. PubMed ID: 22050607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin II type 1 receptor.
    Fukuda K; Hirooka K; Mizote M; Nakamura T; Itano T; Shiraga F
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3629-38. PubMed ID: 20164447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of oxygenated University of Wisconsin solution containing endothelin-A receptor antagonist in twenty-four-hour heart preservation.
    Okada K; Yamashita C; Okada M; Okada M
    J Heart Lung Transplant; 1996 May; 15(5):475-84. PubMed ID: 8771503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of angiotensin II type 1 receptor antagonism on endothelial function: role of bradykinin and nitric oxide.
    Landmesser U; Drexler H
    J Hypertens Suppl; 2006 Mar; 24(1):S39-43. PubMed ID: 16601572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.